Literature DB >> 16402388

Genomic instabilities in squamous cell carcinoma of head and neck from the Indian population.

Susmita Chakrabarti1, Shiladitya Sengupta, Arunava Sengupta, Saminendra Nath Basak, Anup Roy, Chinmay Panda, Susanta Roychoudhury.   

Abstract

Intrinsic genomic instability of an incipient tumor cell drives the development of cancer. In colorectal cancer, an inverse relationship between microsatellite instability (MIN) and chromosomal instability (CIN) has been reported. The relationship between MIN and CIN in head and neck squamous cell carcinoma (HNSCC) is uncertain. In the present study, we examined these two types of instabilities in HNSCC using microsatellite markers and arbitrary primed PCR (APPCR) technique. HNSCC tumors showed high frequency of MIN and loss of heterozygosity (LOH). We observed that, in contrast to colorectal tumors, the frequency of LOH increased with the increase in MIN. There was no significant difference between MIN- and MIN+ groups of HNSCC tumors in the extent of overall genomic alterations; rather higher MIN+ tumors exhibited higher incidence of deletion. Thus, in sporadic HNSCC, both MIN and CIN pathways operate simultaneously to drive tumor formation. Copyright 2006 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402388     DOI: 10.1002/mc.20178

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  2 in total

1.  Role of BMP3 in progression of gastric carcinoma in Chinese people.

Authors:  Xue-Rong Chen; Jin-Wei Wang; Xiang Li; Hong Zhang; Zai-Yuan Ye
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

2.  Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients.

Authors:  Yue-Qin Yang; Liang Wu; Jin-Xing Chen; Jian-Zhong Sun; Meng Li; Dong-Mei Li; Hai-Ying Lu; Zhi-Hong Su; Xin-Qiu Lin; Ji-Cheng Li
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.